Each recipient has a product with significant potential to address a major national priority, such as meeting a large unmet medical need, reducing downstream health care utilization, addressing a public health crisis, boosting domestic manufacturing, or increasing medication affordability with Most Favored Nation pricing.
Beginning with the 2024 performance period/2026 MIPS payment year, the targeted review period closes 30 days following the release of MIPS payment adjustments (refer to 42 CFR 414.1385(a)(2)).
In their letter, the groups called on DHS to issue guidance clarifying that physicians, residents, and fellows are essential to maintaining a strong health care workforce and should be categorically exempt from the fee. The AMA is eager to collaborate with the administration to ensure that patients don’t lose access to care.
Nearly half of U.S. adults—122.4 million people—are living with high blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature death, according to the 2025 American Heart Association Statistical Update.
The Health Resources and Services Administration released new data showing HRSA-funded health centers served over 32.4 million patients in 2024 — the most patients ever served in the Health Center Program’s 60-year history.
On July 31, 2025, the Centers for Medicare & Medicaid Services issued a final rule for updates to Medicare payment policies and rates for skilled nursing facilities under the Skilled Nursing Facility Prospective Payment System for fiscal year 2026.
The CMS Making Health Tech Great Again initiative is announced. “Let’s stop waiting and let’s definitely stop faxing. Let’s start building. The right data at the right time can mean the difference between loss and hope. The time is now. Are you in?”
This program is designed to support communities severely affected by homelessness and to gain insights on effective ways to identify patients, complete treatment, cure infections, and reduce reinfection by Hepatitis C (a liver disease caused by the Hepatitis C virus).
CMS announced that 33 states, plus the District of Columbia and Puerto Rico, will participate in the Cell and Gene Therapy Access Model, a bold new approach to delivering cutting-edge treatments for people on Medicaid living with sickle cell disease.
Through the Wasteful and Inappropriate Service Reduction (WISeR) Model, CMS will partner with companies specializing in enhanced technologies to test ways to provide an improved and expedited prior authorization process relative to Original Medicare’s existing processes, helping patients and providers avoid unnecessary or inappropriate care and safeguarding federal taxpayer dollars.
The American Medical Association and 79 leading medical societies reaffirm their support for vaccination as the best way to protect against the flu, COVID-19, and RSV and their potentially serious complications.
The American Medical Association House of Delegates convened recently at its Annual Meeting to adopt new policies aimed at strengthening medical education and bolstering the future physician workforce. The new policies include efforts to address medical student and physician burnout, support trainees during licensure exams, and advocate for physician-led care.
©2025 Answers Media Company, LLC
Notifications